This Pokémon can't attack during your next turn.
Put 3 Dragon Pokémon from your discard pile onto your Bench. (You can't use more than 1 GX attack in a game.)
Dragon Majesty entered circulation in 2018. Series classification for this set is Sun & Moon.
The checklist contains 80 cards, placing it in a compact expansion range. As of 2026, the set is 8 years old and now falls into an established back-catalog period.
Within this set, Dragonite-GX is card number 67 with a Rare Ultra designation.
Dragonite-GX is a Dragon Majesty card from the 2018 release window. Its card type is Pokémon.
The rarity label is Rare Ultra. Printed HP is 250.
Energy typing is Dragon. This gives collectors a clear identity footprint for the print.
Dragonite-GX evolves from Dragonair. Printed card effect: Pokémon-GX rule: When your Pokémon-GX is Knocked Out, your opponent takes 2 Prize cards.
Dragonite-GX (Dragon Majesty) is presently valued at about $52.09 in raw condition. Compared with last week, pricing is 3.5% higher.
Against its 30-day baseline of $50.28, this card is pricing 3.6% higher. Its 90-day trading band runs between $44.06 and $52.09, producing a 15% range and low-volatility behavior.
The listed rarity for this print is Rare Ultra.
A wider Dragonite-GX checklist helps contextualize this specific Dragonite-GX print. The current sample spans 5 comparable cards from 3 sets.
In this sample, pricing ranges between $10.57 and $116.14 (999% total span). Relative to the alternative average ($50.68), this card is +3%.
Notable alternatives include Dragonite-GX #SM156 (SM Black Star Promos) at $76.75, Dragonite-GX #37 (Dragon Majesty) at $14.77, Dragonite-GX #152 (Unified Minds) at $10.57, and Dragonite-GX #248 (Unified Minds) at $116.14.
Collector-focused market read: Short-term momentum is positive (3.5% over 7 days), while the card sits 18% above its 90-day low. The 90-day range spans $44.06 to $52.09 (15% spread), which indicates low-volatility behavior.
Versus the 30-day average ($50.28), the card is trading 3.6% higher. Top-grade copies show substantial separation from raw: PSA 10 is pricing +351% above the current raw benchmark.
PSA 9 is currently around $57.32, while PSA 10 is $234.87.
